DK1556375T3 - Flavonderivater som inhibitorer af cyklinafhængige kinaser - Google Patents
Flavonderivater som inhibitorer af cyklinafhængige kinaserInfo
- Publication number
- DK1556375T3 DK1556375T3 DK03753911T DK03753911T DK1556375T3 DK 1556375 T3 DK1556375 T3 DK 1556375T3 DK 03753911 T DK03753911 T DK 03753911T DK 03753911 T DK03753911 T DK 03753911T DK 1556375 T3 DK1556375 T3 DK 1556375T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclin
- inhibitors
- dependent kinases
- flavone derivatives
- flavone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN616MU2002 | 2002-07-08 | ||
| PCT/IN2003/000234 WO2004004632A2 (en) | 2002-07-08 | 2003-07-07 | Flavone derivatives as inhibitors of cyclin-dependent kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1556375T3 true DK1556375T3 (da) | 2008-11-03 |
Family
ID=30012269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03753911T DK1556375T3 (da) | 2002-07-08 | 2003-07-07 | Flavonderivater som inhibitorer af cyklinafhængige kinaser |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1556375B1 (zh) |
| JP (1) | JP4860148B2 (zh) |
| KR (1) | KR100991920B1 (zh) |
| CN (1) | CN1668613B (zh) |
| AR (1) | AR041184A1 (zh) |
| AT (1) | ATE399162T1 (zh) |
| AU (1) | AU2003272070B2 (zh) |
| BR (1) | BR0312633A (zh) |
| CA (1) | CA2492130C (zh) |
| DE (1) | DE60321808D1 (zh) |
| DK (1) | DK1556375T3 (zh) |
| ES (1) | ES2309338T3 (zh) |
| IL (1) | IL166153A (zh) |
| MX (1) | MXPA05000388A (zh) |
| NZ (1) | NZ537518A (zh) |
| PT (1) | PT1556375E (zh) |
| RU (1) | RU2334746C2 (zh) |
| TW (1) | TWI331034B (zh) |
| WO (1) | WO2004004632A2 (zh) |
| ZA (1) | ZA200500138B (zh) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7915301B2 (en) | 2002-07-08 | 2011-03-29 | Piramal Life Science Limited | Inhibitors of cyclin dependent kinases and their use |
| EP2046738B1 (en) * | 2006-06-21 | 2014-06-11 | Piramal Enterprises Limited | Enantiomerically pure flavone derivatives for the treatment of proliferative disorders and processes for their preparation |
| AU2006346193C1 (en) * | 2006-07-07 | 2014-02-20 | Piramal Enterprises Limited | An enantioselective synthesis of pyrrolidine-substituted flavones |
| NZ581183A (en) * | 2007-05-15 | 2012-03-30 | Piramal Life Sciences Ltd | Combination of a cytotoxic antineoplastic agent and a cyclin dependent kinase (CDK) inhibitor for the treatment of cancer |
| CN101333205A (zh) * | 2008-07-10 | 2008-12-31 | 大连理工大学 | 周期素依赖蛋白激酶抑制剂黄芩素哌嗪衍生物及其制法 |
| TWI461194B (zh) | 2009-05-05 | 2014-11-21 | Piramal Entpr Ltd | 吡咯啶取代黃酮作為輻射致敏劑 |
| EP2429292B1 (en) * | 2009-05-08 | 2019-04-03 | Georgia State University Research Foundation | Compounds and compositions comprising cdk inhibitors and their use in the treatment of cancer |
| US7928067B2 (en) | 2009-05-14 | 2011-04-19 | Ischemix Llc | Compositions and methods for treating ischemia and ischemia-reperfusion injury |
| NZ602636A (en) * | 2010-02-26 | 2014-08-29 | Piramal Entpr Ltd | Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| EP2640423B1 (en) | 2010-11-18 | 2017-07-26 | Ischemix LLC | Lipoyl compounds and their use for treating ischemic injury |
| WO2012069972A1 (en) | 2010-11-19 | 2012-05-31 | Piramal Life Sciences Limited | A pharmaceutical combination for the treatment of breast cancer |
| BR112013012313A2 (pt) * | 2010-11-19 | 2019-09-24 | Piramal Entpr Ltd | combinação farmacêutica de paclitaxel e um inibidor de cdk |
| TW201242597A (en) | 2011-03-14 | 2012-11-01 | Piramal Life Sciences Ltd | A synergistic pharmaceutical combination for the treatment of pancreatic cancer |
| UY34013A (es) * | 2011-04-13 | 2012-11-30 | Astrazeneca Ab | ?compuestos de cromenona con actividad anti-tumoral?. |
| TW201300105A (zh) * | 2011-05-31 | 2013-01-01 | Piramal Life Sciences Ltd | 治療頭頸鱗狀細胞癌之相乘藥物組合物 |
| WO2012176163A2 (en) | 2011-06-24 | 2012-12-27 | Piramal Enterprises Limited | Compounds for the treatment of cancers associated with human papillomavirus |
| WO2013105056A1 (en) | 2012-01-13 | 2013-07-18 | Piramal Enterprises Limited | Pyrrolidine- substituted flavone derivatives for prevention or treatment of oral mucositis |
| WO2014049515A1 (en) * | 2012-09-25 | 2014-04-03 | Piramal Enterprises Limited | Pyrrolidine substituted flavones for treatment of renal cystic diseases |
| JP6568060B2 (ja) * | 2013-07-12 | 2019-08-28 | ピラマル エンタープライズイズ リミテッド | 黒色腫の治療のための組合せ医薬 |
| EP3148532B1 (en) | 2014-05-28 | 2021-03-03 | Piramal Enterprises Limited | Pharmaceutical combination comprising a cdk inhibitor and a thioredoxin reductase inhibitor for the treatment of cancer |
| KR20180019114A (ko) * | 2015-06-23 | 2018-02-23 | 코베스트로 도이칠란트 아게 | 치환된 트리아진 |
| MX2018011666A (es) | 2016-03-28 | 2019-07-08 | Presage Biosciences Inc | Combinaciones farmaceuticas para el tratamiento de cancer. |
| EP3804724B1 (en) | 2016-10-20 | 2022-12-07 | Pfizer Inc. | Cdk inhibitors for treating pah |
| DK3615023T3 (da) | 2017-04-25 | 2023-09-25 | Ischemix Llc | Lipoyl-glu-ala til behandlingen af neurodegenerativ skade forårsaget af traumatisk hjerneskade |
| CN107573270B (zh) * | 2017-09-29 | 2019-11-29 | 河南师范大学 | 一种α-甲酰基吡咯烷类化合物的合成方法 |
| JP2022512711A (ja) | 2018-10-19 | 2022-02-07 | エフ．ホフマン－ラ ロシュ アーゲー | Ｂ型肝炎ウイルス疾患の処置及び予防のための、クロメン－４－オン誘導体 |
| CN110028475B (zh) * | 2019-05-13 | 2022-07-01 | 中国药科大学 | 基于苯并吡喃结构的新型cdk9抑制剂、其制备方法及应用 |
| CA3163105A1 (en) | 2019-11-28 | 2021-06-03 | Bayer Aktiengesellschaft | Substituted aminoquinolones as dgkalpha inhibitors for immune activation |
| AR121719A1 (es) | 2020-04-03 | 2022-06-29 | Petra Pharma Corp | Inhibidores alostéricos de cromenona del fosfoinosítido 3-quinasa (pi3k) para el tratamiento de enfermedades |
| CA3217937A1 (en) | 2021-05-03 | 2022-11-10 | Erin Danielle ANDERSON | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease |
| TWI829179B (zh) | 2021-05-27 | 2024-01-11 | 美商佩特拉製藥公司 | 用於治療疾病之磷酸肌醇3-激酶(pi3k)異位色烯酮抑制劑 |
| CN113549044B (zh) * | 2021-07-23 | 2024-01-23 | 中国药科大学 | 8-氮杂环取代色酮类衍生物及其制备方法与制药用途 |
| TW202329930A (zh) | 2021-09-30 | 2023-08-01 | 美商佩特拉製藥公司 | 用於治療疾病之磷酸肌醇3-激酶(pi3k)之異位色烯酮抑制劑 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3836676A1 (de) * | 1988-10-28 | 1990-05-03 | Hoechst Ag | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
| US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
| US5849733A (en) * | 1996-05-10 | 1998-12-15 | Bristol-Myers Squibb Co. | 2-thio or 2-oxo flavopiridol analogs |
| CN1433410A (zh) * | 2000-05-03 | 2003-07-30 | 株式会社Lg生命科学 | 具有3－羟基色烯－4－酮结构的cdk抑制剂 |
-
2003
- 2003-06-24 TW TW092117185A patent/TWI331034B/zh not_active IP Right Cessation
- 2003-07-04 AR ARP030102432A patent/AR041184A1/es unknown
- 2003-07-07 PT PT03753911T patent/PT1556375E/pt unknown
- 2003-07-07 WO PCT/IN2003/000234 patent/WO2004004632A2/en active IP Right Grant
- 2003-07-07 BR BR0312633-1A patent/BR0312633A/pt not_active IP Right Cessation
- 2003-07-07 JP JP2004519151A patent/JP4860148B2/ja not_active Expired - Lifetime
- 2003-07-07 KR KR1020057000401A patent/KR100991920B1/ko not_active IP Right Cessation
- 2003-07-07 CA CA2492130A patent/CA2492130C/en not_active Expired - Fee Related
- 2003-07-07 AT AT03753911T patent/ATE399162T1/de active
- 2003-07-07 CN CN038163241A patent/CN1668613B/zh not_active Expired - Lifetime
- 2003-07-07 RU RU2005102939/04A patent/RU2334746C2/ru not_active IP Right Cessation
- 2003-07-07 ES ES03753911T patent/ES2309338T3/es not_active Expired - Lifetime
- 2003-07-07 NZ NZ537518A patent/NZ537518A/en not_active IP Right Cessation
- 2003-07-07 AU AU2003272070A patent/AU2003272070B2/en not_active Ceased
- 2003-07-07 MX MXPA05000388A patent/MXPA05000388A/es active IP Right Grant
- 2003-07-07 DE DE60321808T patent/DE60321808D1/de not_active Expired - Lifetime
- 2003-07-07 DK DK03753911T patent/DK1556375T3/da active
- 2003-07-07 EP EP03753911A patent/EP1556375B1/en not_active Expired - Lifetime
-
2005
- 2005-01-05 IL IL166153A patent/IL166153A/en active IP Right Grant
- 2005-01-06 ZA ZA200500138A patent/ZA200500138B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR041184A1 (es) | 2005-05-04 |
| NZ537518A (en) | 2008-02-29 |
| KR20050017110A (ko) | 2005-02-21 |
| IL166153A0 (en) | 2006-01-15 |
| JP4860148B2 (ja) | 2012-01-25 |
| TWI331034B (en) | 2010-10-01 |
| AU2003272070A1 (en) | 2004-01-23 |
| JP2006502109A (ja) | 2006-01-19 |
| WO2004004632A8 (en) | 2005-03-24 |
| ZA200500138B (en) | 2006-02-22 |
| DE60321808D1 (de) | 2008-08-07 |
| WO2004004632A3 (en) | 2004-09-16 |
| PT1556375E (pt) | 2008-10-03 |
| EP1556375B1 (en) | 2008-06-25 |
| CA2492130C (en) | 2011-09-06 |
| TW200406202A (en) | 2004-05-01 |
| ES2309338T3 (es) | 2008-12-16 |
| ATE399162T1 (de) | 2008-07-15 |
| WO2004004632A2 (en) | 2004-01-15 |
| IL166153A (en) | 2009-11-18 |
| EP1556375A2 (en) | 2005-07-27 |
| MXPA05000388A (es) | 2005-09-30 |
| AU2003272070B2 (en) | 2009-02-26 |
| CN1668613A (zh) | 2005-09-14 |
| CA2492130A1 (en) | 2004-01-15 |
| BR0312633A (pt) | 2005-07-19 |
| CN1668613B (zh) | 2012-07-04 |
| KR100991920B1 (ko) | 2010-11-04 |
| RU2334746C2 (ru) | 2008-09-27 |
| RU2005102939A (ru) | 2005-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1556375T3 (da) | Flavonderivater som inhibitorer af cyklinafhængige kinaser | |
| DK1463506T3 (da) | Substituerede quinazolin-derivater som inhibitorer af aurora-kinaser | |
| DK1562589T3 (da) | Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser | |
| DK1585749T3 (da) | Diazepinoindol-derivater som kinaseinhibitorer | |
| SE0701538L (sv) | Azaspiroalkanderivat som hämmare av metalloproteaser | |
| NO20045220L (no) | Heterocykliske inhibitorer for kinaser | |
| DK1664043T3 (da) | Sammensætninger egnede som inhibitorer af proteinkinaser | |
| DK1581515T3 (da) | Triazolderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase-1 | |
| DK1532138T3 (da) | Inhibitorer af tyrosinkinaser | |
| DK1720882T3 (da) | Pyrazolopyrimidin-derivater som cyclin-afhængige kinaseinhibitorer | |
| DK1686999T3 (da) | Pyrazolderivater som inhibitorer af receptortyrosinkinaser | |
| DK1480962T3 (da) | 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer | |
| DK1786799T3 (da) | Hidtil ukendte phenylaminopyrimidinderivater som inhibitorer af bcr-abl-kinase | |
| DK1438306T3 (da) | Derivater af UK-2A | |
| NO20023828L (no) | Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer | |
| NO20043726L (no) | Heteroarylforbindelser anvendelige som inhibitorer av GSK-3 | |
| NO20050072L (no) | Nye inhibitorer av kinaser | |
| NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
| NO20055421D0 (no) | Kinolinderivater som fosfodiestrase-inhibitorer | |
| DK1562902T3 (da) | 2-pyridonderivater som inhibitorer af neutrofilelastase | |
| DK2039685T3 (da) | Heterobicycliske forbindelser som P38-inhibitorer | |
| DK1658292T3 (da) | Triazologyrimidinderivater som glycogensynthasekinase 3 - inhibitorer | |
| DK1811998T3 (da) | Triazoler anvendelige som inhibitorer af proteinkinaser | |
| DK1763517T3 (da) | Pyrimidinderivater som 11beta-HSD1-inhibitorer | |
| DK1633712T3 (da) | Seks leddede amino-amid derivater som angiogenese inhibitorer |